The COVID-OUT clinical trial found that the common diabetes medication metformin was effective in reducing serious health outcomes of COVID-19 by more than half when
A medication called baricitinib (brand name Olumiant), which is commonly used to treat rheumatoid arthritis, reduces the risk of death by 13% in hospitalized COVID-19
Despite warnings from medical professionals, the social media buzz about ivermectin’s ability to cure COVID has continued. The result has been a tremendous increase in
Existing, inexpensive, and safe drugs that can reduce the impact of COVID-19 infection are gaining some attention. Among these “repurposed” medications, fluvoxamine shows great promise
Media outlets are starting to spread the word about existing, safe, and inexpensive medications that show promise for treatment of COVID-19. CNN’s Dr. Sanjay Gupta
A recent real-world study found that COVID-19 patients treated with fluvoxamine had less severe illness and no hospitalizations. Fluvoxamine is an antidepressant commonly used for
The largest observational study of COVID-19 — including almost 6,000 individuals — has shown that metformin use was associated with decreased mortality in women, but
The Parsemus Foundation has provided seed funding to initiate research on use of the common diabetes medication metformin for prevention and treatment of COVID-19. The
One of the risk factors for severe illness from COVID-19 is diabetes. While scientists aren’t sure why diabetes leads to poorer outcomes for COVID-19 patients,
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:
